Literature DB >> 9469377

Clinical benefit as a primary efficacy endpoint.

E Ballatori, A Del Favero, F Roila.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9469377     DOI： 10.1200/JCO.1998.16.2.803

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy.

Authors:  Davide Tassinari; Luigi Montanari; Marco Maltoni; Michela Ballardini; Alessandra Piancastelli; Marco Musi; Giampiero Porzio; Vincenzo Minotti; Augusto Caraceni; Barbara Poggi; Anna Stella; Federica Aielli; Emanuela Scarpi
Journal:  Support Care Cancer       Date:  2007-07-13       Impact factor: 3.603

2.  Surrogate end points of quality of life assessment: have we really found what we are looking for?

Authors:  Davide Tassinari
Journal:  Health Qual Life Outcomes       Date:  2003-11-24       Impact factor: 3.186
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.